Immune Response in Celiac Disease on In-vitro Gluten Challenge
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 4/17/2018 |
| Start Date: | February 2013 |
| End Date: | March 2018 |
An In-vitro Gluten Challenge on the Immunologic Response in Celiac Disease.
The main purpose of this study is to see how cells taken from the lining of the intestine
behave in the laboratory with exposure to gluten and other substances that act on the immune
system. The cells lining the intestine of a person with celiac disease should be different
than a person without celiac disease. The study doctors would like to see how the cells react
after coming in contact with gluten and if substances that act on the immune system can
prevent gluten related inflammation. Examples of these substances include steroids. The cells
should produce chemicals of their own in response to the gluten. These other chemicals will
be measured and the results compared between those with:
- celiac disease that does not respond to a gluten-free diet (refractory celiac disease)
- celiac disease which is controlled by a gluten-free diet
- uncontrolled celiac disease (either newly diagnosed with celiac disease or not on a
gluten-free diet
- gluten-sensitivity
- disorders other than celiac disease.
behave in the laboratory with exposure to gluten and other substances that act on the immune
system. The cells lining the intestine of a person with celiac disease should be different
than a person without celiac disease. The study doctors would like to see how the cells react
after coming in contact with gluten and if substances that act on the immune system can
prevent gluten related inflammation. Examples of these substances include steroids. The cells
should produce chemicals of their own in response to the gluten. These other chemicals will
be measured and the results compared between those with:
- celiac disease that does not respond to a gluten-free diet (refractory celiac disease)
- celiac disease which is controlled by a gluten-free diet
- uncontrolled celiac disease (either newly diagnosed with celiac disease or not on a
gluten-free diet
- gluten-sensitivity
- disorders other than celiac disease.
The primary purpose of this study is to determine the effect of in-vitro introduction of
gluten on inflammatory response primarily Interferon-γ and other cytokines, such as IL-15,
IL-18 and IL-21, in cultures obtained from small intestinal mucosal biopsy samples of
subjects who underwent upper endoscopy.
Secondary goals include comparing the inflammatory response to immunosuppressants and
cytokines after exposing the cultures obtained from small intestinal mucosal biopsies taken
from RCD I subjects with intestinal mucosal biopsies taken from subjects with CeD controlled
on a Gluten-Free Diet (GFD), uncontrolled CeD, Gluten sensitivity and Non-celiac Controls.
gluten on inflammatory response primarily Interferon-γ and other cytokines, such as IL-15,
IL-18 and IL-21, in cultures obtained from small intestinal mucosal biopsy samples of
subjects who underwent upper endoscopy.
Secondary goals include comparing the inflammatory response to immunosuppressants and
cytokines after exposing the cultures obtained from small intestinal mucosal biopsies taken
from RCD I subjects with intestinal mucosal biopsies taken from subjects with CeD controlled
on a Gluten-Free Diet (GFD), uncontrolled CeD, Gluten sensitivity and Non-celiac Controls.
Inclusion Criteria:
- 18-75 years of age
- Undergoing a clinically indicated upper endoscopy
Exclusion Criteria:
- Anticoagulation or antiplatelet therapy
- Known active non-celiac intestinal inflammatory disorder
We found this trial at
1
site
330 Brookline Ave
Boston, Massachusetts 02215
Boston, Massachusetts 02215
617-667-7000
Principal Investigator: Daniel A Leffler, MD, MS
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials
